AL
ALB.US Albemarle Corp
- Market cap
- USD 11.0B
- P/E
- 22.5x
- P/B
- 1.35x
- ROE
- 13.9%
- Dividend yield
- 3.24%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is ALB.US undervalued?
Graham numberALB.US trades 16.2% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Albemarle Corp fundamental analysis
No fundamental analysis for Albemarle Corp yet.
Albemarle Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Albemarle Corp
Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles; power grids and solar panels; high-performance greases; and specialty glass used in consumer appliances and electronics. The Special…
Full company profileAlbemarle Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Albemarle Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.68B | 3.07B | 3.37B | 3.59B | 3.13B | 3.33B | 7.32B | 9.62B | 5.38B | 5.14B | 6.30B |
| Gross Profit | 971M | 1.12B | 1.22B | 1.26B | 996M | 1.01B | 3.09B | 1.20B | 60.2M | 672M | 1.86B |
| Operating Income | 510M | 623M | 724M | 685M | 526M | 533M | 2.50B | 241M | -636M | 93.8M | 1.11B |
| EBITDA | 736M | 819M | 925M | 899M | 758M | 545M | 3.63B | 2.65B | -294M | 558M | 1.86B |
| Net Income | 644M | 54.9M | 694M | 533M | 376M | 124M | 2.69B | 1.57B | -1.18B | -511M | 1.46B |
| EPS | 5.68 | 0.49 | 6.34 | 5.02 | 3.52 | 1.06 | 23 | 13 | -10 | -4.34 | 12 |
| Balance Sheet | |||||||||||
| Total Assets | 8.16B | 7.75B | 7.58B | 9.86B | 10.5B | 11.0B | 15.5B | 18.3B | 16.6B | 16.4B | 16.1B |
| Total Liabilities | 4.22B | 3.93B | 3.82B | 5.77B | 5.98B | 5.17B | 7.27B | 8.61B | 6.41B | 6.59B | 5.26B |
| Shareholders' Equity | 3.80B | 3.67B | 3.59B | 3.93B | 4.27B | 5.63B | 7.98B | 9.41B | 9.96B | 9.53B | 10.5B |
| Cash & Short-term Investments | 2.27B | 1.14B | 555M | 613M | 747M | 439M | 1.50B | 890M | 1.19B | 1.62B | 1.85B |
| Total Debt | 2.37B | 1.84B | 1.71B | 3.19B | 3.69B | 2.52B | 3.32B | 4.28B | 3.62B | 3.30B | 1.88B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 733M | 304M | 546M | 719M | 799M | 344M | 1.91B | 1.33B | 688M | 1.28B | 1.95B |
| Capital Expenditure | 197M | 318M | 700M | 852M | 850M | 954M | 1.26B | 2.15B | 1.68B | 590M | 334M |
| Free Cash Flow | 537M | -13.7M | -154M | -132M | -51.6M | -609M | 646M | -828M | -993M | 692M | 1.62B |
| Ratios | |||||||||||
| ROE | 17.0% | 1.5% | 19.3% | 13.6% | 8.8% | 2.2% | 33.7% | 16.7% | -11.8% | -5.4% | 13.9% |
| ROA | 7.9% | 0.7% | 9.1% | 5.4% | 3.6% | 1.1% | 17.4% | 8.6% | -7.1% | -3.1% | 9.1% |
| Net Profit Margin | 24.0% | 1.8% | 20.6% | 14.9% | 12.0% | 3.7% | 36.7% | 16.4% | -21.9% | -9.9% | 23.2% |
| Debt to Equity | 0.62x | 0.50x | 0.48x | 0.81x | 0.86x | 0.45x | 0.42x | 0.45x | 0.36x | 0.35x | 0.18x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Albemarle Corp dividends
- Dividend yield
- 3.24%
- Forward dividend
- 1.64 USD
- Payout ratio
- -
- Ex-dividend date
- Dec 18, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 357M | 3.04 | - |
| 2024 | USD 311M | 2.65 | - |
| 2023 | USD 187M | 1.59 | 11.9% |
| 2022 | USD 184M | 1.57 | 6.9% |
| 2021 | USD 178M | 1.53 | 143.8% |
| 2020 | USD 162M | 1.52 | 43.1% |
| 2019 | USD 152M | 1.43 | 28.5% |
| 2018 | USD 145M | 1.32 | 20.8% |
| 2017 | USD 141M | 1.25 | 256.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Mar 2, 2007.
Who owns Albemarle Corp
- Insiders 0.21%
- Institutions 99.79%
- Public & others 0.00%
- Shares outstanding 118M
- Free float 118M
Top funds holding ALB.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| American Funds American Balanced A | 4.00M | 3.39% | 0.00% | Sep 2026 |
| American Funds Growth Fd of Amer A | 3.99M | 3.38% | 0.00% | Sep 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 3.76M | 3.18% | +0.26% | Sep 2026 |
| Vanguard 500 Index Investor | 3.10M | 2.63% | -1.00% | Sep 2026 |
| Vanguard Small Cap Index | 2.66M | 2.25% | -2.12% | Sep 2026 |
| Vanguard PRIMECAP Inv | 1.58M | 1.34% | +1.31% | Sep 2026 |
| iShares Core S&P 500 ETF | 1.57M | 1.33% | +0.17% | Oct 2026 |
| Invesco S&P 500® Equal Weight ETF | 1.57M | 1.33% | +0.17% | Oct 2026 |
| Fidelity 500 Index | 1.53M | 1.30% | +0.18% | Sep 2026 |
| State Street®MatSelSectSPDR®ETF | 1.50M | 1.27% | +1.33% | Oct 2026 |
| State Street® SPDR® S&P 500® ETF | 1.44M | 1.22% | -0.25% | Oct 2026 |
| ProShares S&P 500 Dividend Aristocrats | 1.40M | 1.18% | 0.00% | Oct 2026 |
| VanEck Rare Earth & Strat Mtls ETF | 1.38M | 1.17% | 0.00% | Oct 2026 |
| Franklin Income A1 | 1.33M | 1.12% | 0.00% | Sep 2026 |
| State Street® SPDR® S&P® Dividend ETF | 1.02M | 0.86% | 0.00% | Oct 2026 |
| VictoryShares Free Cash Flow ETF | 975K | 0.83% | +0.34% | Oct 2026 |
| Strategic Advisers Fidelity US TtlStk | 971K | 0.82% | +21.62% | Sep 2026 |
| Vanguard MStar Small Cap Value Index | 864K | 0.73% | +0.31% | Sep 2026 |
| VanEck RreErth&StratMtlsETFA$Acc | 823K | 0.70% | 0.00% | Oct 2026 |
| Fidelity Series Large Cap Stock | 759K | 0.64% | +34.37% | Sep 2026 |
Top institutions holding ALB.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Capital World Investors | 9.90M | 8.39% | +0.68% | Jun 2026 |
| BlackRock Inc | 9.50M | 8.05% | +8.78% | Jun 2026 |
| Vanguard Capital Management, LLC | 7.70M | 6.53% | +0.53% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 6.44M | 5.45% | +1.92% | Jun 2026 |
| State Street Corp | 5.50M | 4.66% | +5.28% | Jun 2026 |
| Barclays PLC | 3.30M | 2.79% | +166.77% | Jun 2026 |
| Geode Capital Management, LLC | 3.13M | 2.65% | -8.85% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 2.90M | 2.45% | +28.83% | Jun 2026 |
| FMR Inc | 2.69M | 2.28% | +1,054.77% | Jun 2026 |
| PRIMECAP Management Company | 2.65M | 2.25% | -0.48% | Jun 2026 |
| Bank of America Corp | 2.54M | 2.16% | -14.55% | Jun 2026 |
| Van Eck Associates Corporation | 2.17M | 1.84% | +7.86% | Jun 2026 |
| Amvescap Plc. | 1.85M | 1.57% | +11.82% | Jun 2026 |
| Qube Research & Technologies | 1.66M | 1.41% | +114.46% | Jun 2026 |
| The Goldman Sachs Group Inc | 1.66M | 1.41% | -0.57% | Jun 2026 |
| JPMorgan Chase & Co | 1.58M | 1.34% | -22.28% | Jun 2026 |
| The Toronto-Dominion Bank | 1.53M | 1.30% | -9.90% | Jun 2026 |
| Two Sigma Investments LLC | 1.46M | 1.24% | -37.06% | Jun 2026 |
| Earnest Partners LLC | 1.43M | 1.21% | -10.56% | Jun 2026 |
| NORGES BANK | 1.39M | 1.18% | +19.33% | Jun 2026 |
Albemarle Corp company profile
- Company name
- Albemarle Corp
- Ticker
- ALB.US
- Exchange
- USA Stocks
- Listed since
- Feb 17, 1994
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 7,800
- Fiscal year end
- December
- Address
- 4250 Congress Street, Charlotte, NC, United States, 28209
- Phone
- 980 299 5700
- Website
- albemarle.com
About Albemarle Corp
Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles; power grids and solar panels; high-performance greases; and specialty glass used in consumer appliances and electronics. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemical products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications, including airbag initiators. This segment also provides organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates for the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and alkylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves the grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals, and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Albemarle Corp management
10- Mr. Jerry Kent Masters Jr.Chairman & CEO · born 1960
- Mr. Neal R. SheoreyCFO & Executive VP · born 1977
- Mr. Mark R. MummertExecutive VP & COO · born 1969
- Mr. Eric W. NorrisExecutive VP & Chief Commercial Officer · born 1967
- Ms. Melissa H. AndersonExecutive VP & Chief Business Transformation Officer · born 1965
- Mr. Max W. HoodChief Accounting Officer · born 1979
- Ms. Meredith H. Bandy C.F.A.Vice President of Investor Relations & Sustainability
- Mr. Ander C. KrupaSenior VP, General Counsel & Corporate Secretary · born 1979
- Ms. Cynthia Renee LimaSenior VP and Chief External Affairs & Communications Officer · born 1962
- Ms. Autumn M. GagarinasSenior VP & Chief People and Workplace Transformation Officer · born 1974